Abstract
Laser photocoagulation has been used successfully for the treatment of clinically significant macular oedema to reduce the risk of loss of vision in diabetic patients. A quantitative method for measuring retinal thickness was applied to 20 patients with diabetic macular oedema before and 4 months after focal laser treatment to assess the reduction in retinal thickening and its relation to visual acuity. The degree of thickening at each location, defined by thickness index, was determined relative to the corresponding average value in normal subjects. Comparison of quantitative retinal thickness measurements before and after treatment demonstrated that treatment at thickness indices of approximately 1.6 (60% thickening) has nearly 50% probability for reversal of thickening to within the normal range (< or = 1.3), whereas at thickness indices greater than 2.8 (180% thickening) there is less than 2.5% probability that reversal will occur. The level of foveal thickening before treatment strongly correlated with the degree of thickening after treatment. Most of the eyes with an improvement in visual acuity had a foveal thickness within the normal range at 4 months' follow up. These findings suggest that quantitative retinal thickness measurement provides an objective assessment of the degree of macular oedema and can be useful for monitoring the efficacy of focal laser treatment in reducing the thickening and relating the latter to visual outcome.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Behrendt T. Therapeutic vascular occlusions in diabetic retinopathy. Argon laser photocoagulation. Arch Ophthalmol. 1972 Jun;87(6):629–633. doi: 10.1001/archopht.1972.01000020631003. [DOI] [PubMed] [Google Scholar]
- Ferris F. L., 3rd, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol. 1984 May;28 (Suppl):452–461. doi: 10.1016/0039-6257(84)90227-3. [DOI] [PubMed] [Google Scholar]
- Haik G. M., Jr, Terrell W. L., 3rd, Haik G. M., Sr Diabetic retinopathy: a leading cause of new blindness. South Med J. 1989 May;82(5):575–579. [PubMed] [Google Scholar]
- Lee C. M., Olk R. J. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology. 1991 Oct;98(10):1594–1602. doi: 10.1016/s0161-6420(91)32082-7. [DOI] [PubMed] [Google Scholar]
- Marcus D. F., Aaberg T. M. Argon laser photocoagulation treatment of diabetic cystoid maculopathy. Ann Ophthalmol. 1977 Mar;9(3):365–372. [PubMed] [Google Scholar]
- Olk R. J. Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology. 1986 Jul;93(7):938–950. doi: 10.1016/s0161-6420(86)33638-8. [DOI] [PubMed] [Google Scholar]
- Shahidi M., Ogura Y., Blair N. P., Rusin M. M., Zeimer R. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol. 1991 Aug;109(8):1115–1119. doi: 10.1001/archopht.1991.01080080075032. [DOI] [PubMed] [Google Scholar]
- Shahidi M., Zeimer R. C., Mori M. Topography of the retinal thickness in normal subjects. Ophthalmology. 1990 Sep;97(9):1120–1124. doi: 10.1016/s0161-6420(90)32457-0. [DOI] [PubMed] [Google Scholar]
- Wiznia R. A. Photocoagulation of nonproliferative exudative diabetic retinopathy. Am J Ophthalmol. 1979 Jul;88(1):22–27. doi: 10.1016/0002-9394(79)90746-3. [DOI] [PubMed] [Google Scholar]
- Zeimer R. C., Shahidi M., Mori M. T., Benhamou E. In vivo evaluation of a noninvasive method to measure the retinal thickness in primates. Arch Ophthalmol. 1989 Jul;107(7):1006–1009. doi: 10.1001/archopht.1989.01070020068031. [DOI] [PubMed] [Google Scholar]